# AttraX® Putty vs. Autograft in XLIF®

> **NCT02250248** · NA · COMPLETED · sponsor: **NuVasive** · enrollment: 45 (actual)

## Conditions studied

- Degenerative Conditions of the Lumbar Spine

## Interventions

- **BIOLOGICAL:** AttraX Putty
- **OTHER:** Iliac Crest Bone Graft (ICBG)

## Key facts

- **NCT ID:** NCT02250248
- **Lead sponsor:** NuVasive
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2021-05-21
- **Final completion:** 2021-05-21
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2025-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02250248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02250248, "AttraX® Putty vs. Autograft in XLIF®". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT02250248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*